Medicina
Departamento
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadoras/es de AstraZeneca (United Kingdom) (5)
2022
-
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888
2017
-
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial
Arthritis and Rheumatology, Vol. 69, Núm. 9, pp. 1903-1913
2016
-
Computational Lexical Analysis of the Language Commonly Used to Describe Gout
Arthritis Care and Research, Vol. 68, Núm. 6, pp. 763-768
2003
-
A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study
Respiratory Medicine, Vol. 97, Núm. 8, pp. 872-881